Is a 29 mm Edwards (Edwards Lifesciences) mitral valve a mechanical valve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is a 29 mm Edwards Mitral Valve a Mechanical Valve?

No, a 29 mm Edwards mitral valve is a bioprosthetic (tissue) valve, not a mechanical valve. Edwards manufactures the Carpentier-Edwards Perimount series, which consists of stented bioprosthetic valves made from bovine pericardium mounted on a stent frame 1.

Valve Classification and Material Composition

Edwards Bioprosthetic Valves

  • The Carpentier-Edwards Perimount is a stented bioprosthetic valve that uses bovine pericardium cut and sewn to stent posts, available in mitral sizes including 25 mm, 27 mm, and 29 mm 1.
  • The normal effective orifice area (EOA) for a 29 mm Carpentier-Edwards Perimount mitral valve is 2.1 ± 0.5 cm² 1.
  • Edwards also manufactures the SAPIEN transcatheter valves, which utilize bovine pericardium leaflets mounted on stainless steel or cobalt-chromium alloy frames 2.

Mechanical Valves in the Mitral Position

  • Mechanical mitral valves are manufactured by different companies, primarily St. Jude Medical (Standard and Regent models) and MCRI On-X 1.
  • For comparison, a 29 mm St. Jude Medical Standard mechanical mitral valve has an EOA of 1.8 ± 0.4 cm², while the MCRI On-X 29 mm has an EOA of 2.2 ± 0.9 cm² 1.
  • Mechanical valves require lifelong anticoagulation with warfarin to prevent thrombosis 3, 4.

Clinical Implications of Valve Type

Bioprosthetic Valve Characteristics

  • Bioprosthetic valves do not require long-term anticoagulation beyond the initial 3-6 months post-implantation, reducing bleeding risk compared to mechanical valves 5, 6.
  • The primary disadvantage is structural valve deterioration requiring reoperation, with the reoperation hazard increasing progressively after 7 years for mitral tissue valves 5.
  • All bioprosthetic tissues undergo glutaraldehyde fixation, which eliminates the need for immunosuppression 2.

Mechanical Valve Characteristics

  • Mechanical valves have superior durability with lower reoperation rates (66% lower risk) compared to bioprosthetic valves 6.
  • However, mechanical valves carry a 20-21% greater risk of major bleeding events and stroke/systemic embolism due to mandatory anticoagulation 6, 7.
  • In patients under 65 years, mechanical mitral valve replacement demonstrates longer estimated survival (13.5 vs 11.3 years) compared to bioprosthetic valves 7.

Common Pitfall to Avoid

Do not confuse valve size with valve type. The 29 mm designation refers only to the labeled size of the prosthesis and cannot be used to determine whether a valve is mechanical or bioprosthetic 1. Both mechanical and bioprosthetic valves are available in 29 mm sizes for mitral position, but they are manufactured by different companies with distinct materials and hemodynamic profiles 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aortic Valve Material Composition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Results with mechanical cardiac valvular prostheses.

The Annals of thoracic surgery, 1995

Research

40 Years experience in mitral valve replacement using Starr-Edwards, St. Jude Medical and ATS valves.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2006

Research

Twenty-year comparison of tissue and mechanical valve replacement.

The Journal of thoracic and cardiovascular surgery, 2001

Research

Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old.

The Journal of thoracic and cardiovascular surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.